Impact of vasodilators on diuretic response in patients with congestive heart failure: a mechanistic trial of cimlanod (BMS ‐986231)
ConclusionsFor patients with heart failure and congestion, vasodilation with agents such as cimlanod reduces the response to diuretic agents, which may offset any benefit from acute reductions in cardiac preload and afterload.This article is protected by copyright. All rights reserved.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Pierpaolo Pellicori,
John G.F. Cleland,
Maria Borentain,
Jorg Taubel,
Fraser Graham,
Javed Khan,
Dario Bruzzese,
Paul Kessler,
John J.V. McMurray,
Adriaan A. Voors,
Christopher M. O'Connor,
John R. Teerlink,
G. Michael Felker Tags: Research Article Source Type: research
More News: Cardiology | Congestive Heart Failure | Furosemide | Heart | Heart Failure | Sodium | Study